CAR-T Congress EU 2020 | Kisaco Research

CAR-T Congress EU

Discovery, Translation, Commercialisation: Developing CAR-T into viable, accessible therapies

Download agenda
London, United Kingdom
29-30 January, 2020

“For me, the CAR-T conference brought together the best experts from those companies and research institutes working on the latest developments in the CAR-T sector.”

Dr. Bodo Kohring Biotechnology Consultant, Kohring Consulting

Why Attend

Be part of the movement as CAR-T Therapy shapes the future of oncology.

The promise of the revolutionary oncology treatment, CAR-T therapy, has become a reality this year, with end-stage cancer patients treated on public health services across the world. As CAR-T moves into the public domain, battle has commenced in the race to effectively commercialise this ground-breaking therapy.

The CAR-T Congress is bringing together leading biotechs, late-stage researchers and global pharmaceutical leaders to promote and share research that will break down barriers in R&D through novel data. In our fourth annual congress, we are introducing a new pre-day focused on NK Cell Therapy and the event will run alongside our Vein-to-Vein Congress, so you can tailor your agenda and learn more about cell therapies and their manufacturing. 

Having listened to the market demands, this year we will be bringing you even more industry-driven understanding of translational applications of the science that drives R&D in CAR-T. Tackle the next hurdles for allogeneic treatments by limiting graft vs host disease through the use of iPSC, and increase the efficacy of these treatments in solid tumours through combination therapies and solid tumour manipulation.

Talks run by biotechs, pharma and regulatory bodies, will put you in a position to make informed decisions when commercialising your CAR-T therapy.

2019 IMAGE GALLERY

CAR-T EU past attendees

TESTIMONIALS

CAR-T EU testimonials

WHO WILL BE THERE

Network with industry experts from:

  • Big pharma and biotech
  • Cell Therapy Academics and clinicians 
  • Process standardisation - technology/services
  • Logistics companies - cell storage/transport
  • Service providers - CRO’s, Consultants, Government

Past attendees include:

CAR-T EU Logo Cloud

The Agenda

We are excited to bring you the agenda for our fourth annual CAR-T Congress EU. This agenda shows you the new talks and other big changes coming this year. We are looking forward to having you back...

Check out the highlights from the CAR-T Congress USA 2018: 

Download agenda

The Speakers

 

Mark Creighton-Gutteridge

Director, Head of Discovery, Oncology Cell Therapy
GSK

Mark Creighton-Gutteridge

Director, Head of Discovery, Oncology Cell Therapy
GSK

Mark Creighton-Gutteridge

Director, Head of Discovery, Oncology Cell Therapy
GSK
 

Bob Valamehr, PhD MBA,

Vice President, Cancer Immunotherapy
Fate Therapeutics Inc

Bob Valamehr, PhD MBA,

Vice President, Cancer Immunotherapy
Fate Therapeutics Inc

Bob Valamehr, PhD MBA,

Vice President, Cancer Immunotherapy
Fate Therapeutics Inc
 

Peggy Sotiropoulou

Director, Research and Development
Celyad

Peggy Sotiropoulou

Director, Research and Development
Celyad

Peggy Sotiropoulou

Director, Research and Development
Celyad
 

Dr John Maher

Clinical Senior Lecturer/Honorary Consultant/CSO
King's College London/Leucid Bio

Dr John Maher

Clinical Senior Lecturer/Honorary Consultant/CSO
King's College London/Leucid Bio

Dr John Maher

Clinical Senior Lecturer/Honorary Consultant/CSO
King's College London/Leucid Bio
 

Professor Hinrich Abken

Professor of Cancer Genetics, Internal Medicine
University Hospital of Cologne

Professor Hinrich Abken

Professor of Cancer Genetics, Internal Medicine
University Hospital of Cologne

Professor Hinrich Abken

Professor of Cancer Genetics, Internal Medicine
University Hospital of Cologne
 

Fiona Thistlethwaite

Christie Foundation, NHS

Fiona Thistlethwaite

Christie Foundation, NHS

Fiona Thistlethwaite

Christie Foundation, NHS
 

Dr. Stefanos Theoharis

Senior VP and Head of Pipeline Strategies
Cell Medica

Dr. Stefanos Theoharis

Senior VP and Head of Pipeline Strategies
Cell Medica

Dr. Stefanos Theoharis

Senior VP and Head of Pipeline Strategies
Cell Medica
 

Karl-Johan Malmberg

Professor of Immunology
University of Oslo

Karl-Johan Malmberg

Professor of Immunology
University of Oslo

Karl-Johan Malmberg

Professor of Immunology
University of Oslo
 

Professor Ann Ager

Personal Chair, School of Medicine
Cardiff University

Professor Ann Ager

Personal Chair, School of Medicine
Cardiff University

Professor Ann Ager

Personal Chair, School of Medicine
Cardiff University
 

Jo Tomlins

Educational Practitioner Nurse
NHS

Jo Tomlins

Educational Practitioner Nurse
NHS

Jo Tomlins

Educational Practitioner Nurse
NHS
 

Dr Sophie Papa

National Institute of Health Research Academic in Medical Oncology
Kings College London

Sophie Papa is a Senior Lecturer and Consultant Medical Oncologist at King’s College London and Guy’s and St Thomas’ NHS Foundation Trust. Sophie undertook her medical training at the University of Oxford and Imperial College London. She completed a PhD in cancer immunotherapy from King’s College London in 2011. She is a clinical academic with research interests in the field of immune-oncology.

Dr Sophie Papa

National Institute of Health Research Academic in Medical Oncology
Kings College London

Dr Sophie Papa

National Institute of Health Research Academic in Medical Oncology
Kings College London

Sophie Papa is a Senior Lecturer and Consultant Medical Oncologist at King’s College London and Guy’s and St Thomas’ NHS Foundation Trust. Sophie undertook her medical training at the University of Oxford and Imperial College London. She completed a PhD in cancer immunotherapy from King’s College London in 2011. She is a clinical academic with research interests in the field of immune-oncology. Her research interests include developing approaches to optimise personalised cell based immune therapies for solid tumour oncology and understanding adverse immune reactions triggered by checkpoint inhibitor therapy. She is also interested in the delivery of complex cell therapy trials for solid tumour indications. Sophie is a medical oncologist with a practice in malignant melanoma and is the lead for skin cancer research at Guy’s and St Thomas’ NHS Foundation Trust. 

 

Roberto Spada

Business Development Specialist, Mass Cytometry
Fluidigm

Roberto Spada

Business Development Specialist, Mass Cytometry
Fluidigm

Roberto Spada

Business Development Specialist, Mass Cytometry
Fluidigm
 

Jacqueline Barry

Chief Clinical Officer
Cell & Gene Therapy Catapult

Jacqueline Barry

Chief Clinical Officer
Cell & Gene Therapy Catapult

Jacqueline Barry

Chief Clinical Officer
Cell & Gene Therapy Catapult
 

Antonio di Rocco

Cell Therapy Applications Manager
Miltenyi Biotech

Antonio di Rocco

Cell Therapy Applications Manager
Miltenyi Biotech

Antonio di Rocco

Cell Therapy Applications Manager
Miltenyi Biotech
 

Dr Leila Alland

Chief Medical Officer
Affimed

Dr Leila Alland

Chief Medical Officer
Affimed

Dr Leila Alland

Chief Medical Officer
Affimed
 

David Finlay

Associate Professor
Trinity College Dublin

David Finlay

Associate Professor
Trinity College Dublin

David Finlay

Associate Professor
Trinity College Dublin
 

Salim Khakoo

Professor of Heptology
University of Southampton

Salim Khakoo

Professor of Heptology
University of Southampton

Salim Khakoo

Professor of Heptology
University of Southampton
 

Prof. Torsten Tonn

Group Leader
Univesitat Dresden

Prof. Torsten Tonn

Group Leader
Univesitat Dresden

Prof. Torsten Tonn

Group Leader
Univesitat Dresden
 

Adrian Bot

VP Translational Medicine
Kite Pharma

Adrian Bot

VP Translational Medicine
Kite Pharma

Adrian Bot

VP Translational Medicine
Kite Pharma
 

Deepak Raj

Centre for Tumour Biology
Bart's Cancer Institute

Deepak Raj

Centre for Tumour Biology
Bart's Cancer Institute

Deepak Raj

Centre for Tumour Biology
Bart's Cancer Institute
 

Duncan McKay

VP General Manager Europe
Sangamo Therapeutics

Duncan McKay

VP General Manager Europe
Sangamo Therapeutics

Duncan McKay

VP General Manager Europe
Sangamo Therapeutics
 

Stefan Wildt

Head, Pharmaceutical Sciences and Cell Therapies Translational Engine
Takeda

Stefan Wildt

Head, Pharmaceutical Sciences and Cell Therapies Translational Engine
Takeda

Stefan Wildt

Head, Pharmaceutical Sciences and Cell Therapies Translational Engine
Takeda
 

Pierre Heimendinger

VP Process Development
Sangamo Therapeutics

Pierre Heimendinger

VP Process Development
Sangamo Therapeutics

Pierre Heimendinger

VP Process Development
Sangamo Therapeutics
 

Emanuele Ostuni

Head of Cell & Gene Therapy Europe
Novartis

Emanuele Ostuni

Head of Cell & Gene Therapy Europe
Novartis

Emanuele Ostuni

Head of Cell & Gene Therapy Europe
Novartis
 

Louise Bisset

Biopharmaceutical Qaulity Assessor
MHRA

Louise Bisset

Biopharmaceutical Qaulity Assessor
MHRA

Louise Bisset

Biopharmaceutical Qaulity Assessor
MHRA
 

Qasim Rafiq

Bioprocessing
UCL

Qasim Rafiq

Bioprocessing
UCL

Qasim Rafiq

Bioprocessing
UCL
 

Ali Mohamed

VP CMC
Immatics Biotechnologies

Ali Mohamed

VP CMC
Immatics Biotechnologies

Ali Mohamed

VP CMC
Immatics Biotechnologies
 

Dr Detlev Parow

Head of Department of Medicines, Therapeutic Appliances and Remedies
DAK-Gesundheit

Dr Detlev Parow

Head of Department of Medicines, Therapeutic Appliances and Remedies
DAK-Gesundheit

Dr Detlev Parow

Head of Department of Medicines, Therapeutic Appliances and Remedies
DAK-Gesundheit

Poster Session: CAR-T Congress EU 2020

Our dedicated poster session is the perfect way to get your research noticed. In order to present a poster at the forum, you need to be registered as a delegate. Please note that there are 15 assigned spaces for the CAR-T Congress and 10 for the NK Summit Day. Poster space is assigned on a first come, first served basis (subject to checks and successful registration).

At the Congress, your presentation will be displayed in a dedicated poster area. The poster presentation session will take place at the afternoon networking break on day one.

Submit your poster here

Poster abstract submission deadline is on 6th December 2019. Abstracts received after this time may not be accepted so please submit your abstract as soon as possible!

Posters should be sized A0 (841mm x 1189mm) in portrait orientation.

Expertise Partner

Innovation Partner

Event Partner

Become a Sponsor

Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.
Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.

Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:
Thursday, September 19, 2019 to Friday, January 31, 2020
Academic: NK Pre-Conference Day
£399 + VAT
Must be a full time academic or healthcare professional
1 day conference pass
Networking opportunities
Refreshments, breakfast & lunch
Thursday, September 19, 2019 to Friday, January 31, 2020
Biotech: NK Pre-Conference Day
£499 + VAT
Revenue under £5m
1 day conference pass
Networking opportunities
Refreshments, breakfast & lunch
Thursday, September 19, 2019 to Friday, January 31, 2020
Industry/Service Provider: NK Pre-Conference Day
£999 + VAT
Upgrade your conference pass for £499
1 day conference pass
Networking opportunities
Refreshments, breakfast & lunch
Preparing registration...

Book a Team to Save More!

PLEASE NOTE: Team Discounts are only available for Industry Pricing
Book a Team of 3+
 - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

Payment Terms for Combined CAR-T Congress Europe:

  • Please note that a £49 processing fee will apply to any invoices requested.
  • All Prices are in GBP and are exclusive of VAT @ 20%
  • All Early Bird discount prices, including Group Discounts, must be paid in full by deadlines provided above.
  • No discounts or offers can be combined with any other offer.
  • Please view our Cancellation Policy.
  • QUESTIONS? Please email [email protected].

Pass Features:

  • 2 Day conference pass
  • Networking Sessions
  • Lunch and Refreshments
  • Complimentary Articles and Content

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Other events you might be interested in:

CAR-T Congress USA 2019

Therapeutic Genome Editing Congress

European Protein Degradation Congress